Menarini Asia-Pacific
↗Singapore, Singapore
Menarini Asia-Pacific is a member of the Menarini Group, the largest Italian biopharmaceutical company. In Asia-Pacific, Menarini has a direct presence in 13 major healthcare markets, managing the entire commercial value chain from clinical development and regulatory approval to product launch and lifecycle management. The company focuses on delivering proprietary and partnered brands across a wide range of therapeutic areas.
The company operates as a bridge for Western pharmaceutical companies looking to enter the complex Asian markets. They possess deep expertise in local regulatory requirements and have a robust distribution network. Their portfolio includes a mix of consumer health products, aesthetics, and high-tech specialty medicines, particularly in oncology and cardiovascular health.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Commercialization & Distribution
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B-$5B
Founded:2011
Ownership:subsidiary
Status:operating
FUNDING
Investors:The Menarini Group
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved
Modalities:Small molecule, mAb, ADC, Diagnostics
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 15 | Phase 3: 10 | Phase 4: 8
FDA Approvals:5
EMA Approvals:8
CORPORATE STRUCTURE
Parent Company:The Menarini Group (A. Menarini I.F.R. S.r.l.)
Subsidiaries:Menarini Korea, Menarini China, Menarini Australia, Menarini Thailand
Key Partnerships:Radius Health (Elacestrant licensing), Melinta Therapeutics (Vabomere), SciClone Pharmaceuticals, Helsinn
COMPETITION
Position:Leader
Competitors:Zuellig Pharma, DKSH, Takeda, Astellas, Eisai
LEADERSHIP
Key Executives:
Maurizio Luongo - CEO, Menarini Asia-Pacific
Donghwan Kim - General Manager, Korea
Board Members:Eric Cornut (Chairman)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Menarini Asia-Pacific. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.